株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

細菌性膣炎:世界の治験レビュー

Bacterial Vaginosis Global Clinical Trials Review, H1, 2017

発行 GlobalData 商品コード 244195
出版日 ページ情報 英文 121 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.66円で換算しております。
Back to Top
細菌性膣炎:世界の治験レビュー Bacterial Vaginosis Global Clinical Trials Review, H1, 2017
出版日: 2017年04月30日 ページ情報: 英文 121 Pages
概要

当レポートでは、世界の細菌性膣炎治療薬の臨床試験について調査し、地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、 中断(一時中止、廃止、打ち切り)された試験のリストなどを提供してお届けします。

イントロダクション

  • 細菌性膣炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 上位5ヶ国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 上位5ヶ国における治験件数; 中東/アフリカ地域
    • 主要国における治験件数; 中南米

G7諸国における治験件数

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数

フェーズ(相)別治験件数: E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

治験主要参加企業 - 細菌性膣炎 治療薬

有望な薬剤

  • 最新治験ニュース

治験のプロファイル

  • 代表的な企業の治験の概要
    • Starpharma Holdings Limited
    • Symbiomix Therapeutics, LLC
    • Merck & Co., Inc.
    • Ferring International Center S.A.
    • AmVac AG
    • Osel Inc.
    • Mission Pharmacal Company
    • Actavis plc
    • Arun Pharmaceuticals Limited
    • Alfa Wassermann S.p.A
  • 代表的な研究機関/病院の治験の概要
    • University of Alabama at Birmingham
    • University of Pittsburgh
    • Shiraz University of Medical Sciences
    • Lawson Health Research Institute
    • Centers for Disease Control and Prevention
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • Mount Sinai Hospital
    • The National Institute of Allergy and Infectious Diseases
    • Ahvaz Jundishapur University of Medical Sciences

5大治験プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Bacterial Vaginosis Global Clinical Trials Review, H1, 2017" provides an overview of Bacterial Vaginosis clinical trials scenario. This report provides top line data relating to the clinical trials on Bacterial Vaginosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Bacterial Vaginosis Therapeutics Clinical Trials 30
  • Prominent Drugs 32
  • Latest Clinical Trials News on Bacterial Vaginosis 33
  • Mar 30, 2017: VivaGel BV phase 3 trials for prevention of BV completed 33
  • Clinical Trial Profile Snapshots 34

Appendix 116

  • Abbreviations 116
  • Definitions 116
  • Research Methodology 117
  • Secondary Research 117
  • About GlobalData 118
  • Contact Us 118
  • Source 119

List of Tables

List of Tables

  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
  • Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 12
  • Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 14
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase, 2017* 21
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32

List of Figures

List of Figures

  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
  • Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
  • Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
  • Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 12
  • Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 13
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 14
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 17
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
  • GlobalData Methodology 117
Back to Top